Opportunity overview
Awarded under PSR Direct Award C - Pathology Services
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
THE DOCTORS LABORATORY LIMITED
Matched by exact name
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 007363-2025-1
- Status
- active
- Identifier
- 02201998
- Location
- London, UKH12, WC1H 9AX, United Kingdom
Classification
- CPV85111800 — Pathology services
Lots
- Awarded under PSR Direct Award C - Pathology Services, Lifetime value of the contract £5,100.000. Start - 01/04/2025 - End - 31/03/2028. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 11.03.2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.’<br/><br/>Email address where written representations should be sent - ccs.procurementteam@nhs.net <br/>- Award decision-makers; Gemma Buckle - Senior Contract and Relationship Manager and Ellen Ballentyne - Head of iCaSH<br/>- Existing supplier for pathology testing, advantageous cost saving to remain and renew contract. No issues with current supply, supplier meeting expectations on requirements. Net Zero Targets, Carbon Footprint and Reviewing of consumable suppliers are a key focus for the relationship and provider. A price review and reduction has been met by the Provider.<br/>Waste Reduction/ Initiatives are on-going and progressive and support the Trusts Green Plan.<br/><br/>Conflicts of interest identified among the group. The non-conflicted members have assessed the nature and risk of this conflict, and have decided which steps to take to avoid or manage it. Potential steps may include: excluding the conflicted member from related discussions, excluding the conflicted member from decision-making, delegating the matter to a sub-committee of non-conflicted decision-makers, or seeking independent advice to help make the decision.Value not stated